Imprimis Pharma (IMMY) Says It's Making Available Two Glaucoma Drugs on FDA's Drug Shortage List

January 30, 2018 8:16 AM

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced that it is now dispensing preservative-free dorzolamide and a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found